Cargando…

Triglyceride-Glucose Index and Intravenous Thrombolysis Outcomes for Acute Ischemic Stroke: A Multicenter Prospective–Cohort Study

BACKGROUND: The triglyceride-glucose (TyG) index has recently been proposed as a reliable marker of insulin resistance. There is insufficient evidence to verify that the TyG index is correlated with functional outcomes and hemorrhagic transformation and in patients with stroke treated with intraveno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Sheng-Feng, Hu, Han-Hwa, Chao, Hai-Lun, Ho, Bo-Lin, Chen, Chih-Hung, Chan, Lung, Lin, Huey-Juan, Sun, Yu, Lin, Yung-Yang, Chen, Po-Lin, Lin, Shinn-Kuang, Wei, Cheng-Yu, Lin, Yu-Te, Lee, Jiunn-Tay, Chao, A-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890321/ https://www.ncbi.nlm.nih.gov/pubmed/35250801 http://dx.doi.org/10.3389/fneur.2022.737441

Ejemplares similares

Low Cholesterol Levels Increase Symptomatic Intracranial Hemorrhage Rates After Intravenous Thrombolysis: A Multicenter Cohort Validation Study
por: Lin, Sheng-Feng, et al.
Publicado: (2019)

Comparison of Different Dosages of Alteplase in Atrial Fibrillation–Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan
por: Lin, Sheng‐Feng, et al.
Publicado: (2022)

Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)

Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)

Intravenous Thrombolysis Administration 3–4.5 h After Acute Ischemic Stroke: A Retrospective, Multicenter Study
por: Chen, Yu-Wei, et al.
Publicado: (2019)

Neutrophil‐to‐lymphocyte ratio, hyperglycemia, and outcomes in ischemic stroke patients treated with intravenous thrombolysis
por: Cheng, Yani, et al.
Publicado: (2020)

Serum lipid level is not associated with symptomatic intracerebral hemorrhage after intravenous thrombolysis for acute ischemic stroke
por: Lin, Ting-Chun, et al.
Publicado: (2018)

Efficacy and Safety of Endovascular Treatment versus Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials
por: Lin, Chao, et al.
Publicado: (2013)

Stroke Code Improves Intravenous Thrombolysis Administration in Acute Ischemic Stroke
por: Chen, Chih-Hao, et al.
Publicado: (2014)

Decrease in intravenous thrombolysis and poor short-term functional prognosis for acute ischemic stroke during the COVID-19 pandemic
por: Xu, Xueqian, et al.
Publicado: (2021)

Association of triglyceride-glucose index with clinical outcomes in patients with acute ischemic stroke receiving intravenous thrombolysis
por: Toh, Emma M. S., et al.
Publicado: (2022)

Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3–4.5 h
por: Chen, Chih-Hao, et al.
Publicado: (2022)

Safety and Efficacy of Tirofiban During Intravenous Thrombolysis Bridging to Mechanical Thrombectomy for Acute Ischemic Stroke Patients: A Meta-Analysis
por: Li, Wei, et al.
Publicado: (2022)

Midterm Prognosis of Patients With Pulmonary Embolism Receiving Catheter‐Directed Thrombolysis or Systemic Thrombolysis: A Nationwide Population‐Based Study
por: Lin, Donna Shu‐Han, et al.
Publicado: (2021)

Commentary: Neutrophil-Related Ratios Predict the 90-Day Outcome in Acute Ischemic Stroke Patients After Intravenous Thrombolysis
por: MM, Youwei Lin, et al.
Publicado: (2022)

Leukoaraiosis and risk of intracranial hemorrhage and outcome after stroke thrombolysis
por: Yang, Chun-Ming, et al.
Publicado: (2018)

Prognostic value of subclinical thyroid dysfunction in ischemic stroke patients treated with intravenous thrombolysis
por: Zhang, Xiaohao, et al.
Publicado: (2019)

Impact of glycosylated hemoglobin on early neurological deterioration in acute mild ischemic stroke patients treated with intravenous thrombolysis
por: Han, Lin, et al.
Publicado: (2023)

Impact of MCA stenosis on the early outcome in acute ischemic stroke patients
por: Jeng, Jiann-Shing, et al.
Publicado: (2017)

Comparisons of outcomes in stroke subtypes after intravenous thrombolysis
por: Pan, Yi-Ting, et al.
Publicado: (2016)

Semantic Visualization in Functional Recovery Prediction of Intravenous Thrombolysis following Acute Ischemic Stroke in Patients by Using Biostatistics: An Exploratory Study
por: Hsiao, Chih-Chun, et al.
Publicado: (2023)

Remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke
por: He, Yao‐De, et al.
Publicado: (2020)

High Neutrophil-to-Lymphocyte Ratio Predicts Hemorrhagic Transformation in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis
por: Liu, Yong-Lin, et al.
Publicado: (2020)

Mean Platelet Volume-To-Lymphocyte Ratio Predicts Poor Functional Outcomes Among Ischemic Stroke Patients Treated With Intravenous Thrombolysis
por: Chen, Si-Yan, et al.
Publicado: (2019)

Proteinuria Independently Predicts Unfavorable Outcome of Ischemic Stroke Patients Receiving Intravenous Thrombolysis
por: Chen, Chih-Hao, et al.
Publicado: (2013)

The safety and efficacy of tPA intravenous thrombolysis for treating acute ischemic stroke patients with a history of cerebral hemorrhage
por: Zhao, Guang-jian, et al.
Publicado: (2019)

A New Nomogram for Predicting the Risk of Intracranial Hemorrhage in Acute Ischemic Stroke Patients After Intravenous Thrombolysis
por: Weng, Ze-An, et al.
Publicado: (2022)

The white blood cell count to mean platelet volume ratio for ischemic stroke patients after intravenous thrombolysis
por: Weng, Yiyun, et al.
Publicado: (2022)

Association of serum biomarkers with early neurologic improvement after intravenous thrombolysis in ischemic stroke
por: Cui, Yu, et al.
Publicado: (2022)

Intravenous Thrombolysis in Ischemic Stroke Patients With Active Cancer
por: Selvik, Henriette Aurora, et al.
Publicado: (2018)

Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
por: Nam, Ki-Woong, et al.
Publicado: (2017)

Persistent Inequities in Intravenous Thrombolysis for Acute Ischemic Stroke in the United States: Results from the Nationwide Inpatient Sample
por: Sun, Philip, et al.
Publicado: (2023)

Elevation of troponin I in acute ischemic stroke
por: Su, Yu-Chin, et al.
Publicado: (2016)

Serum 25-hydroxyvitamin D deficiency predicts poor outcomes among acute ischemic stroke patients receiving intravenous thrombolysis
por: Wei, Lei, et al.
Publicado: (2019)

Endovascular thrombectomy without versus with intravenous thrombolysis in acute ischemic stroke: a non-inferiority meta-analysis of randomized clinical trials
por: Lin, Chun-Hsien, et al.
Publicado: (2022)

The association between malnutrition status and hemorrhagic transformation in patients with acute ischemic stroke receiving intravenous thrombolysis
por: Kim, Yerim, et al.
Publicado: (2023)

Variants of WNT7A and GPR124 are associated with hemorrhagic transformation following intravenous thrombolysis in ischemic stroke
por: Ta, Song, et al.
Publicado: (2020)

Decreased Lymphocyte-to-Monocyte Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Treated with Thrombolysis
por: Ren, Hao, et al.
Publicado: (2017)

Outcomes and Treatment Complications of Intravenous Urokinase Thrombolysis in Acute Ischemic Stroke in China
por: Zhang, Rongrong, et al.
Publicado: (2021)

Intravenous Thrombolysis May Not Improve Clinical Outcome of Acute Ischemic Stroke Patients Without a Baseline Vessel Occlusion
por: Tian, Huiqiao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b6jtpk2ejkar7a6tca0rnp1kf3